Measures of quality indicators for palliative care in patients with acute myeloid leukaemia receiving ePSC intervention or late referral PC
| ePSC, all | Late PC, all | RD, % (95% CI) | P value | ePSC, deceased | Late PC, deceased | RD, % (95% CI) | P value | |||||
| n/n | % | n/n | % | n/n | % | n/n | % | |||||
| Psychological support*, n (%) | 72/131 | 55 | 41/84 | 49 | 61.5 (−7.5 to 19.8) | 0.3781 | 39/75 | 52 | 22/40 | 55 | −3 (−22.1 to 16.1) | 0.7588 |
| Assessing and managing pain*, n (%) | 131/131 | 100 | 39/84 | 46 | 53.6 (43 to 64.2) | <0.00001 | 75/75 | 100 | 18/40 | 45 | 55 (39.5 to 70.4) | <0.00001 |
| Discussion of GOC/prognosis*, n (%) | 94/131 | 71.8 | 36/84 | 43 | 28.9 (15.8 to 42) | <0.00001 | 70/75 | 93.3 | 16/40 | 40 | 53.3 (37.1 to 69.5) | <0.00001 |
| Promotion of ACP*, n (%) | 75/131 | 57.3 | 2/84 | 2.3 | 54.9 (45.8 to 64) | <0.00001 | 64/75 | 85.3 | 2/40 | 5 | 80.3 (69.8 to 90.8) | <0.0001 |
| Discussion of resuscitation preference*, n (%) | 16/131 | 12.2 | 2/84 | 2.3 | 9.83 (3.3 to 16.3) | 0.01111 | 15/75 | 20 | 2/40 | 5 | 15 (3.7 to 26.3) | 0.0309 |
| Home-care service utilisation*, n (%) | 57/131 | 43.5 | 12/84 | 14.2 | 29.2 (17.9 to 40.5) | <0.00001 | 48/75 | 64 | 12/40 | 30 | 34 (16.1 to 51.9) | 0.0005 |
| Median duration of home care, days (range) | 63.5 (3.0–3273.0) | 53.0 (1–96) | 57.0 (3.0–394.0) | 53.0 (1–96) | ||||||||
| Median time from GOC to death, days (range) | NA | NA | 106 (4.0–585.0) | 149.5 (11–1714) | ||||||||
| Median time from ACP to death, days (range) | NA | NA | 25 (4.0–401.0) | 5.5 (4–7) | ||||||||
*Indicators of quality for palliative care.30
ACP, advance care planning; ePSC, early palliative supportive care; GOC, goals of care; late PC, late referral to palliative care; NA, not applicable; RD, risk difference.